These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35068452)

  • 1. Late-Life Physical Activities Moderate the Relationship of Amyloid-β Pathology with Neurodegeneration in Individuals Without Dementia.
    Sohn BK; Byun MS; Yi D; Jeon SY; Lee JH; Choe YM; Lee DW; Lee JY; Kim YK; Sohn CH; Lee DY;
    J Alzheimers Dis; 2022; 86(1):441-450. PubMed ID: 35068452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
    Moon SW; Byun MS; Yi D; Kim MJ; Jung JH; Kong N; Jung G; Ahn H; Lee JY; Kang KM; Sohn CH; Kim YK; Lee DY;
    J Alzheimers Dis; 2023; 93(1):87-95. PubMed ID: 36938732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study.
    Kim JW; Byun MS; Yi D; Lee JH; Ko K; Jeon SY; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    PLoS Med; 2020 Feb; 17(2):e1003022. PubMed ID: 32097439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    Lee SH; Byun MS; Lee JH; Yi D; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    J Alzheimers Dis; 2020; 75(3):767-777. PubMed ID: 32333586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive decline.
    Jeon SY; Byun MS; Yi D; Jung G; Lee JY; Kim YK; Sohn CH; Kang KM; Lee YJ; Lee DY;
    Psychiatry Clin Neurosci; 2023 Apr; 77(4):205-212. PubMed ID: 36527292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Life Cognitive Activity Is Related to Reduced Neurodegeneration in Alzheimer Signature Regions in Late Life.
    Ko K; Byun MS; Yi D; Lee JH; Kim CH; Lee DY
    Front Aging Neurosci; 2018; 10():70. PubMed ID: 29623037
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic associations of in vivo pathology influence Alzheimer's disease susceptibility.
    Seo J; Byun MS; Yi D; Lee JH; Jeon SY; Shin SA; Kim YK; Kang KM; Sohn CH; Jung G; Park JC; Han SH; Byun J; Mook-Jung I; Lee DY; Choi M;
    Alzheimers Res Ther; 2020 Nov; 12(1):156. PubMed ID: 33213512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ankle-Brachial Index Is Associated with Cerebral β-Amyloid Deposition in Cognitively Normal Older Adults.
    Moon SW; Byun MS; Yi D; Lee JH; Jeon SY; Lee Y; Kee BS; Lee DY;
    J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1141-1148. PubMed ID: 29982493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies.
    Choe YM; Byun MS; Yi D; Lee JH; Jeon SY; Sohn BK; Kim YK; Shin SA; Sohn CH; Lee YJ; Lee DY;
    Alzheimers Res Ther; 2019 Sep; 11(1):79. PubMed ID: 31511066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI.
    Byun MS; Jung JH; Sohn BK; Yi D; Lee JH; Jeon SY; Lee Y; Jung GJ; Lee JY; Kim YK; Shin SA; Sohn CH; Kang KM; Lee DY;
    Psychiatry Clin Neurosci; 2020 May; 74(5):303-310. PubMed ID: 31985106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
    Carneiro CG; Faria DP; Coutinho AM; Ono CR; Duran FLS; da Costa NA; Garcez AT; da Silveira PS; Forlenza OV; Brucki SMD; Nitrini R; Busatto G; Buchpiguel CA
    Braz J Psychiatry; 2022 Aug; 44(5):495-506. PubMed ID: 36420910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midlife Lifestyle Activities Moderate APOE ε4 Effect on
    Jeon SY; Byun MS; Yi D; Lee JH; Ko K; Sohn BK; Lee JY; Ryu SH; Lee DW; Shin SA; Kim YK; Kang KM; Sohn CH; Lee DY
    Front Aging Neurosci; 2020; 12():42. PubMed ID: 32256335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment.
    Weise CM; Chen K; Chen Y; Kuang X; Savage CR; Reiman EM;
    Neuroimage Clin; 2018; 20():286-296. PubMed ID: 30101060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology.
    Kim T; Yi D; Byun MS; Ahn H; Jung JH; Kong N; Kim MJ; Jung G; Lee JY; Lee YS; Kim YK; Lee DY;
    Alzheimers Res Ther; 2022 Dec; 14(1):193. PubMed ID: 36566225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation.
    Arenaza-Urquijo EM; Bejanin A; Gonneaud J; Wirth M; La Joie R; Mutlu J; Gaubert M; Landeau B; de la Sayette V; Eustache F; Chételat G
    Neurobiol Aging; 2017 Nov; 59():72-79. PubMed ID: 28764930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum zinc levels and in vivo beta-amyloid deposition in the human brain.
    Kim JW; Byun MS; Yi D; Lee JH; Kim MJ; Jung G; Lee JY; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY;
    Alzheimers Res Ther; 2021 Nov; 13(1):190. PubMed ID: 34798903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.